Jason Chesney, MD, PhD
James Graham Brown Cancer · University of Louisville · James Graham Brown Cancer Center, University of Louisville
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jason Chesney, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:28 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT02990416 · A-dmDT390-bisFv(UCHT1) Fusion Protein With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV MelanomaVirogen Biotechnology Inc. · unknown · Stage IV Melanoma · principal investigator
- Ph1/Ph2NCT02009397 · A Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma PatientsUniversity of Louisville · completed · Metastatic Melanoma · principal investigator
- Ph1/Ph2NCT01888081 · A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation for Treatment of Stage IV MelanomaVirogen Biotechnology Inc. · terminated · Melanoma · principal investigator
- Ph2NCT00299689 · Phase II Trial of Ontak With Metastatic MelanomaJames Graham Brown Cancer Center · completed · Malignant Melanoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.